Technology | December 08, 2014

COR Medical Technologies Launches CORcare System to Improve Cardiovascular Outcomes

Relational database comprises thousands of symptoms, imaging findings and other tools for point-of-care diagnosis

December 8, 2014 – COR Medical Technologies (COR) introduces CORcare, a comprehensive instant outcome support system for rapid and accurate diagnosis, treatment, and follow-up management of patients with acute and chronic, common and rare diseases involving the cardiovascular system. Developed by Vincent Friedewald, M.D., FACC, COR is a relational database comprising thousands of signs and symptoms, imaging findings, laboratory abnormalities, electrocardiographic results, body area networking (BAN) measures, and genomics, as well as drugs and devices used for treatment. CORcare is available to healthcare professionals on a variety of technology platforms including mobile devices. Targeted users of CORcare include physicians, emergency medical technicians, nurse practitioners, physician assistants, nurses, physician groups, hospitals and academic institutions and their students. 

CORcare helps healthcare professionals consider all possible conditions associated with any single or combination of clinical features for rapid assistance in differential diagnosis and narrowing down to the final diagnosis. It is the first system to embed American College of Cardiology Foundation/American Heart Association (ACCF/AHA) Guidelines specific to data points within each condition, providing instant graded opinions of leading authorities. This feature fully supports and uses the “Guideline Directed Medical Therapy (GDMT)” initiative of the AHA and ACC.  

Also based on ACCF/AHA Guidelines, CORcare provides order sets for many of the common conditions, a feature proven to reduce physician ordering time by up to 50 percent. After diagnoses and management strategies are in place, CORcare provides a secure platform for patient follow-up – called MyCOR – which includes tools to improve medication adherence and other telemedicine functions.

CORcare has other applications as well, all aimed at improving outcomes, such as a “Structured Primary Experiential Learning (SPEL)” professional education module.

CORcare also provides a means for gathering otherwise unattainable clinical outcome data directly from patients themselves. By incorporating the new ICD-10 coding requirements and appropriate XML structures in database construction, CORcare can be integrated with electronic health records.  

Currently, there are three options to sign up for CORcare: standard, premium and organization. The standard option, which is read-only, is free. The premium option, which is currently available for a 30-day free trial, is $240 a year.

For more information: www.cormedtec.com

Related Content

MyoKardia Presents Additional Positive Data From Phase 2 PIONEER-HCM Study at HFSA 2017
News | Heart Failure| September 21, 2017
MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study...
Heart Failure Market to Surpass $16 Billion by 2026
News | Heart Failure| September 19, 2017
The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain, the U.K. and Japan is...
NIAID Scientists Illuminate Mechanism of Increased Cardiovascular Risks With HIV
News | Cardiac Diagnostics| September 14, 2017
September 14, 2017 — Scientists at the National Institutes of Health have expanded the understanding of how chronic i
Marijuana Associated With Three-Fold Risk of Death From Hypertension
News | Hypertension| September 14, 2017
Marijuana use is associated with a three-fold risk of death from hypertension, according to research published recently...
News | Cardiac Diagnostics| September 12, 2017
Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke and heart attack,...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
PURE study may cause revision of fat intake guidelines for cardiology.
Feature | ESC| September 07, 2017
September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of
Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing| September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure| September 06, 2017
September 6, 2017 — Physicians identified a majority of patients with advanced...
Israeli Hospital Completes First Implant of CORolla Heart Failure Device
News | Heart Failure| September 05, 2017
Rambam Hospital in Haifa, Israel, recently became the first to use the CORolla device from Israeli start-up company...
Overlay Init